TB-500 & BPC-157 5MG/5MG

TB-500 & BPC-157 Combination (10 mg) — Dual-Peptide Research Blend

TB-500 and BPC-157 Combination at 10 mg total peptide content is a dual-peptide research formulation that pairs two of the most extensively studied tissue-active peptides in the contemporary research literature. This combination product provides investigators with a pre-formulated blend of thymosin beta-4 fragment (TB-500) and Body Protection Compound-157 (BPC-157), enabling studies that examine potential synergistic or additive interactions between these two mechanistically distinct peptide sequences in a single experimental system.

TB-500, derived from the actin-binding domain of thymosin beta-4, is primarily studied for its effects on cytoskeletal dynamics, cellular migration, and angiogenesis in vitro, while BPC-157 has been investigated for its roles in fibroblast proliferation, growth factor receptor modulation, and nitric oxide system regulation. The combination format addresses a growing trend in peptide research toward multi-component experimental designs that more closely approximate the complex peptide milieu found in biological systems. Researchers can utilize this formulation to compare single-agent versus combination effects on endpoint measures such as cell viability, migration distance, tube formation, and gene expression profiles.

The 10 mg total peptide content is suitable for pilot studies and initial characterization experiments. Each lot is manufactured under controlled conditions with full analytical testing. Coffee & Pepper Peptides supplies this combination product exclusively for laboratory research purposes. It is not intended for human or veterinary use.

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

Coffee & Pepper Peptides operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.